What's new

PSUSA/00010355/202409

PSUSA/00010355/202409

May 27, 2025 - 13:35
 0
PSUSA/00010355/202409
PSUSA/00010355/202409
Read More

Tags:

Previous Article

EMEA-003306-PIP01-22

Next Article

Human medicines European public assessment report (EPAR): Calquence, acalabrutin...

Related Posts

Human medicines European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya), clopidogrel, Date of authorisation: 20/09/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

Strengthening evidence generation in the EU, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 June 2025, 14:00 (CEST) to 10 June 2025, 15:00 (CEST)

Strengthening evidence generation in the EU, Online, Eu...

May 28, 2025  0

Human medicines European public assessment report (EPAR): Isentress, raltegravir, Date of authorisation: 19/12/2007, Revision: 44, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0